Journal article
Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS
Abstract
Objective: To evaluate the cost effectiveness of a new product, oral ganciclovir, in comparison to a current therapy, intravenous (IV) ganciclovir, in the maintenance treatment of newly diagnosed cytomegalovirus (CMV) retinitis in patients with AIDS.Design: This was a retrospective economic study of a prospective non-blinded randomised clinical trial. The model included IV ganciclovir induction, IV or oral ganciclovir maintenance and IV …
Authors
Rachlis A; Smaill F; Walker V; Walker V; Jones A
Journal
PharmacoEconomics, Vol. 16, No. 1, pp. 71–84
Publisher
Springer Nature
Publication Date
7 1999
DOI
10.2165/00019053-199916010-00007
ISSN
1170-7690